ClinicalTrials.gg
Drug

Linsitinib clinical trials

Also written OSI-906 and OSI-906AA.

studies test it
27
open now
2
in phase 3
4
first study started
2007

How each study uses linsitinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the linsitinib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

linsitinib
11
IGF-1R inhibitor OSI-906
3

Development codes

OSI-906
19
OSI-906AA
2
ASP7487
1

Studies by the year they started

26 studies that test it; most in 2012 (6)

Studies that test linsitinib, by start year
YearStudies
20072
20081
20094
20102
20115
20126
20131
20142
20221
20231
20261

Who runs them

Industry 13 · Other 14

Astellas Pharma Inc (8) · Sling Therapeutics, Inc. (3) · National Cancer Institute (NCI) (3) · Astellas Pharma Global Development, Inc. (2) · Emory University (2) · Vanderbilt-Ingram Cancer Center (2) · SCRI Development Innovations, LLC (1) · University of Oxford (1)

Often tested with

Tested in the same studies.

Erlotinib (3) · Paclitaxel (2) · Bortezomib (1) · Dexamethasone (1) · Gemcitabine (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses linsitinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 27

See all 27 studies that test linsitinib →

Codes

What other systems call linsitinib · ClinicalTrials.gg INT005685

  • UNII (FDA) 15A52GPT8TLINSITINIBConfirmed FDA, Wikidata
  • Wikidata Q6554803linsitinibConfirmed FDA, Wikidata
  • NCI Thesaurus C70982LinsitinibOne source FDA
  • DrugBank DB06075One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.